Angry Birds Maker ROVIO will go public with $1 billion value

The Finnish mobile gaming company ROVIO has announced that its initial public offering will value it at $1 billion. The preliminary range of shares will be between 10.25 euros to 11.50 euros each, for a market capitalization of 802 million euros and 896 million euros.

According to initial media reports, the Angry Birds maker could have valuation at up to $2 billion. The listing would help the company expand further. ROVIO IPO will help the company buy more businesses and expand into more profitable territories.

ROVIO is targeting a $1 billion IPO

The company expects to sell 55 percent of its shares during the ROVIO IPO. This would help the company raise 438 million to 488 million euros. Only 30 million of this would go into ROVIO’s coffers. A majority of the money raised will go to shareholders including Trema International, as well as venture capital firms Accel Partners and Atomico.

Trema Internation is owned by Kaj Hed, the uncle of ROVIO co-founder Niklas Hed. Kaj Hed is expected to keep a stake of 37 percent in the company after the listing. This figure is down from the earlier 67 stake in ROVIO.

Angry Birds ROVIO IPO

ROVIO CEO Kati Levoranta said the listing “will offer new shareholders an opportunity to become part of Rovio’s success.”

The subscription period for the ROVIO IPO will begin on September 18 and end on September 26. ROVIO will also open to international offering on the same day and end on September 28.

ROVIO’s overnight success came with Angry Birds came after producing 51 unsuccessful games. In 2009, the company was close to bankruptcy; they had to create the perfect game, something original. Then came the Angry Birds which was a huge flop when it first hit the app store. It took three months to take off in the lucrative English-speaking market.

Today, ROVIO a global entertainment company built on the incredible success of the hit mobile game Angry Birds. David Cameron and Justin Bieber say they are fans of the game Angry Birds.

ROVIO is no longer a mobile gaming company. At the height of the popularity of Angry Birds, the company ventured into films and merchandize. With the money raised from the initial public offering, ROVIO will be able to move towards films and deliver a significant boost to revenues to investors.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.
58 mins ago
Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans ahead to raise new outcomes by 2030. Environmentalists also add to the bar by shaking things with vehicle emission rules by 2026.
4 hours ago
General Motors Q2 2021 Results Recap

General Motors Q2 2021 Results Recap

General Motors Q2 earnings and revenue missed Wall Street’s expectations even though the world’s leading automaker beat earnings projections.
24 hours ago
UK casts doubt over Nvidia’s Arm acquisition over security risks

UK casts doubt over Nvidia’s Arm acquisition over security risks

UK considers blocking Nvidia’s Arm acquisition due to potential risks to national security. The $40 billion takeover faces similar fate in America, China and the European Union.
1 day ago
PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo will sell Tropicana and other juice brands to a private equity firm in exchange for pre-tax proceeds of 3.3 billion dollars.
2 days ago
Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.
2 days ago